All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
Name | Current message text |
---|---|
h English (en) | Treatment of [[megaloblastic anemia]] with concurrent vitamin {{chem|B|12}} deficiency using {{chem|B|12}} vitamers (including cyanocobalamin), creates the possibility of [[hypokalemia]] due to increased [[erythropoiesis]] (red blood cell production) and consequent cellular uptake of [[potassium]] upon anemia resolution. When treated with cyanocobalamin, patients with [[Leber's disease]] may develop serious [[optic atrophy]], possibly leading to blindness. |
h Japanese (ja) | ビタミン{{chem|B|12}}欠乏を同時に伴う[[megaloblastic anemia/ja|巨赤芽球性貧血]]の治療に{{chem|B|12}}ビタミン(シアノコバラミンも含む)を用いると、貧血解消時に[[erythropoiesis/ja|赤血球産生]]の亢進とそれに伴う[[potassium/ja|カリウム]]の細胞内取り込みにより[[hypokalemia/ja|低カリウム血症]]になる可能性がある。シアノコバラミンで治療した場合、[[Leber's disease/ja|リーバー病]]患者は重篤な[[optic atrophy/ja|視神経萎縮]]を発症し、失明に至る可能性がある。 |